History of suicidal behaviour and analgesic use in community-dwelling elderly

Psychotherapy and Psychosomatics

Volumn 82, Issue 5, 2013, Pages 341-343

  Olié, Emilie ^a,b,c,e   Courtet, Philippe ^a,b,c   Poulain, Vanessa ^a   Guillaume, Sébastien ^a,b,c   Ritchie, Karen ^a,b,d   Artero, Sylvaine ^a,c  

^a Montpellier 1 University   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

^d ST MARY S HOSPITAL   (United Kingdom)

^e LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; OPIATE; PSYCHOTROPIC AGENT; ANTIDEPRESSANT AGENT; NARCOTIC ANALGESIC AGENT;

ALCOHOL CONSUMPTION; CHRONIC PAIN; DEMENTIA; DEPRESSION; EDUCATION; FOLLOW UP; HEALTH STATUS; HOSPITALIZATION; HUMAN; LETTER; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NOCICEPTION; PRESCRIPTION; PRIORITY JOURNAL; SELF MEDICATION; SMOKING; SOCIAL ISOLATION; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT DURATION; AGED; AGING; CHRONIC DISEASE; CONSULTATION; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DEMOGRAPHY; DRUG USE; HEADACHE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEDICAL HISTORY; MENTAL PATIENT; PAIN; PATIENT SELECTION; RISK FACTOR;

AGED; ANALGESICS; CASE-CONTROL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; SUICIDE, ATTEMPTED;

EID: 84883201223     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000350504     Document Type: Letter

References (10)

1. Courtet P, Gottesman II, Jollant F, Gould TD: The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies? Transl Psychiatry 2011; 1:e7.
2. Sinyor M, Howlett A, Cheung AH, Schaffer A: Substances used in completed suicide by overdose in Toronto: an observational study of coroner's data. Can J Psychiatry 2012; 57: 184-191.
3. De Leo D, Burgis S, Bertolote JM, Kerkhof AJ, Bille-Brahe U: Definitions of suicidal behavior: lessons learned from the Who/Euro multicentre study. Crisis 2006; 27: 4-15.
4. Ritchie K, Artero S, Beluche I, Ancelin ML, Mann A, Dupuy AM, Malafosse A, Boulenger JP: Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147-152.
5. Radloff P: The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
6. WHO: Cancer pain relief: with a guide to opioid availability. Geneva, 1996.
7. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G: Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13:e58-e68.
8. Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R: The association of depression and painful physical symptoms-a review of the European literature. Eur Psychiatry 2006; 21: 379-388.
9. Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G: Comparative effectiveness of secondgeneration antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety 2012; 29: 379-388.
10. Andersson HI, Ejlertsson G, Leden I, Schersten B: Impact of chronic pain on health care seeking, self-care, and medication. Results from a population-based Swedish study. J Epidemiol Community Health 1999; 53: 503-509.